Question 1

Has Ryan Wakim received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $771,682 in general payments to Ryan Wakim across 961 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Ryan Wakim did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Ryan Wakim come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Johnson & Johnson	440	$344,886
Axsome Therapeutics, Inc.	287	$293,588
AbbVie	105	$111,453
Neuronetics, Inc.	79	$11,350
Alkermes, Inc.	11	$6,971
Teladoc Health, Inc.	3	$2,600
Neurocrine Biosciences, Inc.	4	$248
Sunovion Pharmaceuticals Inc.	8	$143
Takeda Pharmaceuticals U.S.A., Inc.	5	$75
Indivior Inc.	4	$71
Vanda Pharmaceuticals Inc.	2	$55
Neos Therapeutics, LP	2	$39
Otsuka America Pharmaceutical, Inc.	2	$39
Lundbeck LLC	2	$38
Brainsway USA Inc	2	$34
Janssen Scientific Affairs, LLC	1	$31
MDD US Operations, LLC	1	$20
Biogen	1	$15
Shire North American Group Inc	1	$15
Alfasigma USA, Inc.	1	$12

Ryan Wakim

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Wheeling